Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2
Cell Systems · 2025
DOI: 10.1016/j.cels.2025.101391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Systems, 2025. Verfasst von Roy A Ehling und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosystems Science and Engineering, ETH Zurich, Basel 4056, Switzerland. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, SARS-CoV-2, Spike Glycoprotein, Coronavirus, COVID-19. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, Fondation Botnar, Eidgenössische Technische Hochschule Zürich.
Abstract (Originalsprache)
The COVID-19 pandemic showcased a coevolutionary race between the human immune system and SARS-CoV-2, during which the immune system generated neutralizing antibodies targeting the SARS-CoV-2 spike protein's receptor-binding domain (RBD), crucial for host cell invasion, while the virus evolved to evade antibody recognition. Here, we establish a synthetic coevolution system combining high-throughput screening of antibody and RBD variant libraries with protein mutagenesis, surface display, and deep sequencing. Additionally, to significantly extend our interrogation of sequence space, we train a protein language model that predicts antibody escape to RBD variants and demonstrate its capability to generalize to a larger mutational load and mutations at positions unseen during training. Through explainable AI techniques, we probe the model and identify biologically meaningful coevolution trends. Synthetic coevolution reveals antagonistic and compensatory mutational trajectories of neutralizing antibodies and SARS-CoV-2 variants, enhancing the understanding of this evolutionary conflict.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosystems Science and Engineering, ETH Zurich, Basel 4056, Switzerland.
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
- Department of Biosystems Science and Engineering, ETH Zurich, Basel 4056, Switzerland; Basel Research Centre for Child Health, Basel 4056, Switzerland.
- Alloy Therapeutics (Switzerland) AG, Basel 4058, Switzerland.
- Department of Biosystems Science and Engineering, ETH Zurich, Basel 4056, Switzerland; Basel Research Centre for Child Health, Basel 4056, Switzerland; Botnar Institute of Immune Engineering, Basel 4056, Switzerland. El…
Förderung
- Swiss National Science Foundation
- Fondation Botnar
- Eidgenössische Technische Hochschule Zürich
- ETH Zürich Foundation
Zitieren
APA
Ehling, R. A., Minot, M., Overath, M. D., Sheward, D. J., Han, J., Gao, B., Taft, J. M., Pertseva, M., Weber, C. R., Frei, L., Bikias, T., Murrell, B., & Reddy, S. T. (2025). Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2. Cell Systems. https://doi.org/10.1016/j.cels.2025.101391
Vancouver
Ehling RA, Minot M, Overath MD, Sheward DJ, Han J, Gao B, et al. Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2. Cell Systems. 2025. doi:10.1016/j.cels.2025.101391
BibTeX
@article{Ehling2025,
author = {Ehling, Roy A and Minot, Mason and Overath, Max D and Sheward, Daniel J and Han, Jiami and Gao, Beichen and Taft, Joseph M and Pertseva, Margarita and Weber, Cédric R and Frei, Lester and Bikias, Thomas and Murrell, Ben and Reddy, Sai T},
title = {Synthetic coevolution reveals adaptive mutational trajectories of neutralizing antibodies and SARS-CoV-2},
journal = {Cell Systems},
year = {2025},
doi = {10.1016/j.cels.2025.101391}
}
EUVIMED